, Tracking Stock Market Picks
Enter Symbol:
Rxi Pharmaceuticals (RXII) [hlAlert]

Mkt Outperform
down 65.34 %

RXI PHARMACEUTICALS (RXII) rated Mkt Outperform with price target $8 by Rodman & Renshaw

Posted on: Monday,  Dec 21, 2009  9:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform galena biopharma (NASDAQ: GALE) on 12/21/2009, when the stock price was $4.30.
Since then, galena biopharma has lost 65.35% as of 01/21/2016's recent price of $1.49.
If you would have followed this Rodman & Renshaw's recommendation on GALE, you would have lost 65.34% of your investment in 2222 days.

RXi Pharmaceuticals Corporation (RXi) is a discovery-stage biopharmaceutical company pursuing therapeutics based on ribonucleic acid interference (RNAi) for the treatment of human diseases. The Company is focused on internal research and development programs on certain inflammatory and metabolic diseases, and to pursue other therapeutic areas with potential partners. RXi commenced operations after CytRx Corporation contributed to the Company its portfolio of RNAi therapeutic assets, which consisted primarily of RNAi licenses and related intellectual property, and a nominal amount of equipment. As of December 31, 2008, the Company had not generated any revenues.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy